RED DEER, AB, April 6, 2021 /CNW/ - Stigma Grow ("Stigma" or
the "Company") and its parent company, CanadaBis Capital Inc.
(TSXV: CANB), are thrilled to announce they have entered into a
third-party production agreement (the "Agreement") with Sundial
Growers Inc. (NASDAQ: SNDL) ("Sundial" or the "Company"), a
Health Canada licensed cannabis producer recognized for its
'small-batch-at-scale' individualized 'room' approach, to produce a
variety of Sundial's hydrocarbon (BHO) concentrates.
Among other opportunities within the concentrates market, the
new collaboration between the two Alberta-based companies will
enable capitalization on the fast-emerging live-resin vape
market.
Under the terms of the Agreement, Sundial will provide its input
for both fresh-frozen and cured formats to Stigma to produce a
variety of live-resin and cured cannabis concentrates.
Sundial expects to launch the products across Canada under the Top Leaf brand in Q3
2021.
"As one of the first-to-market producers of true live-resin,
high-terpene, full-spectrum vape cartridges in Alberta we reviewed many partnership requests
from some of legal cannabis' most recognizable brands, but none
provided the brand and business fit demonstrated by Sundial," said
Travis McIntyre, CEO of Stigma. "We
look forward to working with this well-established Alberta brand
long into the future and recognize the value that comes to those
who partner strategically with like-minded visionaries."
"As part of our continued focus within the premium inhalable
segment, we are pleased to enter into a concentrates partnership
with Stigma," added Andrew Stordeur,
President and Chief Operating Officer of Sundial. "We believe
this collaboration will provide our consumers with an excellent
addition to our portfolio of cannabis products."
In addition to this partnership announcement, the first two
months of 2021 has seen the Company's existing and new products
accepted into Ontario,
British Columbia, Manitoba and Saskatchewan, as education surrounding the
quality and experience offered by live-resin concentrates makes its
way across the country to millions of recreational and medicinal
consumers typically looking for something new and improved.
About CanadaBis Capital Inc. & Stigma
Grow
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated
Canadian cannabis company focused on achieving large-scale growth
in the global cannabis market – with specific attention paid to
supplying the fast-emerging concentrates category through their
Stigma Grow cultivation and extraction facility.
Acting as the cornerstone for everything they offer, Stigma Grow
continuously strives to address the market demands and lingering
stigmas within the legal cannabis industry head-on, with products
designed to disturb the status quo and dramatically shift the
conversation surrounding Canada's
legal cannabis industry.
About Sundial Growers Inc.
Sundial is a public company with Common Shares traded on
Nasdaq under the symbol "SNDL".
Sundial is a licensed producer that crafts cannabis using
state-of-the-art indoor facilities. Our 'craft-at-scale' modular
growing approach, award-winning genetics and experienced growers
set us apart.
Our Canadian operations cultivate small-batch cannabis using an
individualized "room" approach, with 448,000 square feet of total
available space.
Sundial's brand portfolio includes Top Leaf, Sundial Cannabis,
Palmetto and Grasslands. Our consumer-packaged goods experience
enables us to not just grow quality cannabis, but also to create
exceptional consumer and customer experiences.
We are proudly Albertan, headquartered in Calgary, AB, with operations in Olds, AB,
and Rocky View County, AB.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION:
This news release includes certain "forward-looking statements"
under applicable Canadian securities legislation. Forward-looking
statements include but are not limited to statements with respect
to our business and operations; timing of the Sundial products
coming to market; the demand and market for live-resin vape
cartridges, and our general business plans. Forward-looking
statements are necessarily based upon a number of assumptions
including: the ability of the Company's products to compete with
the pricing and product availability on the black-market; the
market demand for the Company's products; and assumptions
concerning the Company's competitive advantages. These assumptions,
while considered reasonable, are subject to known and unknown
risks, uncertainties, and other factors which may cause actual
results and future events to differ materially from those expressed
or implied by such forward-looking statements. Such factors
include, but are not limited to: compliance with extensive
government regulation, the general business, economic, competitive,
political and social uncertainties; ability to sustain or create a
demand for a product; requirement for further capital; delay or
failure to receive board, shareholder or regulatory approvals; the
results of operations and such other matters as set out in the
Company's continuous disclosure on SEDAR at www.sedar.com. There
can be no assurance that such statements will prove to be accurate,
as actual results and future events could differ materially from
those anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended. The
Company does not intend, and does not assume any obligation, to
update this forward-looking information except as otherwise
required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE CanadaBis Capital Inc.